Diagnosis and treatment of new idiopathic interstitial pneumonias cases: Analysis using the Japanese Registry.

T. Ogura (Yokohama, Japan), R. Okuda (Yokohama, Japan), Y. Kondoh (Seto, Japan), H. Taniguchi (Seto, Japan), T. Johkoh (Amagasaki, Japan), J. Fukuoka (Nagasaki, Japan), A. Miyamoto (Tokyo, Japan), R. Egashira (Saga, Japan), A. Hebisawa (Asahi, Japan), F. Sakai (Hidaka, Japan), T. Takemura (Yokohama, Japan), K. Tomii (Kobe, Japan), K. Fujimoto (Kurume, Japan), T. Tanaka (Sayama, Japan), T. Arai (Sakai, Japan), H. Sumikawa (Sakai, Japan), T. Kasai (Sakai, Japan), Y. Nakamura (Hamamatsu, Japan), T. Iwasawa (Yokohama, Japan), Y. Terasaki (Tokyo, Japan), T. Suda (Hamamatsu, Japan), T. Fujisawa (Hamamatsu, Japan), N. Ishikawa (Hiroshima, Japan), N. Arai (Kana, Japan), T. Takihara (Isehara, Japan), M. Hamaguchi (Izumo, Japan), M. Toyoshima (Hamamatsu, Japan), M. Abe (Chiba, Japan), M. Kato (Tokyo, Japan), H. Miyata (Tokyo, Japan), N. Ichihara (Tokyo, Japan), S. Morita (Kyoto, Japan), N. Inase (Hiratsuka, Japan), H. Tomioka (Kobe, Japan), M. Bandoh (Shimotsuke, Japan), K. Kobayashi (Hidaka, Japan), T. Nukiwa (Sendai, Japan)

Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Session: Clinical aspects of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 759
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Ogura (Yokohama, Japan), R. Okuda (Yokohama, Japan), Y. Kondoh (Seto, Japan), H. Taniguchi (Seto, Japan), T. Johkoh (Amagasaki, Japan), J. Fukuoka (Nagasaki, Japan), A. Miyamoto (Tokyo, Japan), R. Egashira (Saga, Japan), A. Hebisawa (Asahi, Japan), F. Sakai (Hidaka, Japan), T. Takemura (Yokohama, Japan), K. Tomii (Kobe, Japan), K. Fujimoto (Kurume, Japan), T. Tanaka (Sayama, Japan), T. Arai (Sakai, Japan), H. Sumikawa (Sakai, Japan), T. Kasai (Sakai, Japan), Y. Nakamura (Hamamatsu, Japan), T. Iwasawa (Yokohama, Japan), Y. Terasaki (Tokyo, Japan), T. Suda (Hamamatsu, Japan), T. Fujisawa (Hamamatsu, Japan), N. Ishikawa (Hiroshima, Japan), N. Arai (Kana, Japan), T. Takihara (Isehara, Japan), M. Hamaguchi (Izumo, Japan), M. Toyoshima (Hamamatsu, Japan), M. Abe (Chiba, Japan), M. Kato (Tokyo, Japan), H. Miyata (Tokyo, Japan), N. Ichihara (Tokyo, Japan), S. Morita (Kyoto, Japan), N. Inase (Hiratsuka, Japan), H. Tomioka (Kobe, Japan), M. Bandoh (Shimotsuke, Japan), K. Kobayashi (Hidaka, Japan), T. Nukiwa (Sendai, Japan). Diagnosis and treatment of new idiopathic interstitial pneumonias cases: Analysis using the Japanese Registry.. 759

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical categorisation of idiopathic interstitial pneumonias
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004


Pathology of idiopathic interstitial pneumonias
Source: International Congress 2016 – Russia Session
Year: 2016

Chronic granulomatous disease diagnosed in adulthood- Report of 2 Cases
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

Familial cases of idiopathic pulmonary fibrosis: Clinical observation
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011


Clinical value of cluster analysis of unclassifiable idiopathic interstitial pneumonias phenotypes
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020


Clinical features of patients with desquamative interstitial pneumonia: Association with autoimmune disorders
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010


Biopsy documented idiopathic interstitial pneumonias - Analysis of diagnostic yield, survival and mortality over 9 years
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013


Clinical management of the idiopathic interstitial pneumonias: an example of an integrated approach to interstitial lung diseases
Source: Annual Congress 2006 - PG8 - Interstitial lung diseases: idiopathic interstitial pneumonias
Year: 2006


Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?
Source: Eur Respir Rev 2014; 23: 308-319
Year: 2014



Prevalence and clinical characteristics of unclassifiable idiopathic interstitial pneumonias (IIPs)
Source: International Congress 2017 – Novel and old entities
Year: 2017


Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia
Source: International Congress 2014 – ILDs 4
Year: 2014

Diagnostic mistakes in patients with idiopathic interstitial pneumonias (IIP)
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome
Source: International Congress 2014 – ILDs 2
Year: 2014

Long-term survival analysis: Pirfenidone compared to standard care for the treatment of patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014


B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014


Tuberculosis in patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
Source: ERJ Open Res, 6 (2) 00184-2019; 10.1183/23120541.00184-2019
Year: 2020